Daewon Pharmaceutical

Daewon Pharmaceutical, established in 1958, is a specialized pharmaceutical and healthcare company founded on the philosophy of "partner for people to promise their healthy lives." This core tenet guides its continuous efforts to protect human health, adapting to evolving environments. Operating primarily in Asia with a B2B model, the company leverages advanced facilities and significant investment in research and development to drive innovation within the pharmaceutical sector. Its commitment to excellence is reflected in its industry focus and dedication to scientific advancement.

The company's R&D prowess has led to the development of key products, notably the 'Pelubi Tab,' a novel drug designed for both the Korean and international markets. Daewon Pharmaceutical emphasizes a culture where every employee is dedicated to its mission as a companion for customer well-being, fostering growth through integrity. Meet Daewon Pharmaceutical's team to gain insight into the leadership and personnel committed to upholding these high standards and advancing the company's objectives in healthcare.

Customer value is the paramount core principle in Daewon Pharmaceutical's corporate management. The company upholds faith and trust through transparent operations, ensuring all manufactured products are safe for use without hesitation. With a reported revenue of $404.1M and operating from a single primary location, Daewon Pharmaceutical maintains a focused strategy on delivering high-quality pharmaceutical solutions and maintaining its role as a trusted partner in health.